The biggest study to date on new blood tests to detect and analyze cancerous tumors concluded that such “liquid biopsies” are a reliable alternative to conventional biopsies, offering a potentially cheaper and less invasive way of monitoring malignancies. The test used in the study is made by Guardant Health, which also funded the effort.
Trending:
Guardant: ‘Liquid biopsy’ offers hope as cancer blood test